-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AOPaEYBIGtodkwp37d8woVi2l5XzuS7xtMKrckC0WVBWuXCKaB/U5P3iTKXr5zZy g14V//Sadtbx83nba5eAzw== 0001238916-05-000007.txt : 20050617 0001238916-05-000007.hdr.sgml : 20050617 20050617184316 ACCESSION NUMBER: 0001238916-05-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050617 FILED AS OF DATE: 20050617 DATE AS OF CHANGE: 20050617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUECHLER KENNETH F CENTRAL INDEX KEY: 0001238916 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 05904171 BUSINESS ADDRESS: STREET 1: C/O BIOSITE INC STREET 2: 11030 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584554808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-06-17 0 0000834306 BIOSITE INC BSTE 0001238916 BUECHLER KENNETH F BIOSITE INCORPORATED 11030 ROSELLE STREET SAN DIEGO CA 92121 1 1 0 1 Pres. & Chief Scientific Offic Pres. & Chief Scientific Offic Incentive Stock Option (right to buy) 53.38 2005-06-17 4 A 0 1873 0 A 2015-06-17 Common Stock 1873 1873 D Non-Qualified Stock Option (right to buy) 53.38 2005-06-17 4 A 0 53127 0 A 2015-06-17 Common Stock 53127 53127 D Option vests in sixteen equal quarterly installments over four years (on each quarterly anniversary of the applicable vesting commencement date), provided that no shares may be exercised during the first six (6) month period following the commencement of vesting. By: Robyn Shutak For: Kenneth F. Buechler 2005-06-17 -----END PRIVACY-ENHANCED MESSAGE-----